These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 31445586)

  • 1. Angel-Korman A, Stern L, Sarosiek S, et al. Long-term outcome of kidney transplantation in AL amyloidosis. Kidney Int. 2019;95:405-411.
    Kidney Int; 2019 Sep; 96(3):796. PubMed ID: 31445586
    [No Abstract]   [Full Text] [Related]  

  • 2. Improved outcomes for kidney transplantation in AL amyloidosis: impact on practice.
    Nuvolone M; Merlini G
    Kidney Int; 2019 Feb; 95(2):258-260. PubMed ID: 30665564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum to Heybeli C, Bentall A, Wen J, et al. A study from The Mayo Clinic evaluated long-term outcomes of kidney transplantation in patients with immunoglobulin light chain amyloidosis. Kidney Int. 2021;99:707-715.
    Heybeli C; Bentall A; Wen J; Alexander MP; Buadi FK; Cosio FG; Dean PG; Dispenzieri A; Dingli D; El Ters M; Gertz MA; Amer H; Kapoor P; Khamash H; Kourelis T; Kumar S; Lorenz EC; Mai M; Muchtar E; Murray DL; Prieto M; Schinstock CA; Stegall MD; Warsame R; Leung N
    Kidney Int; 2021 Dec; 100(6):1348-1349. PubMed ID: 34802563
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term outcomes of patients with light chain amyloidosis (AL) after renal transplantation with or without stem cell transplantation.
    Herrmann SM; Gertz MA; Stegall MD; Dispenzieri A; Cosio FC; Kumar S; Lacy MQ; Dean PG; Prieto M; Zeldenrust SR; Buadi FK; Russell SJ; Nyberg SL; Hayman SR; Dingli D; Fervenza FC; Leung N
    Nephrol Dial Transplant; 2011 Jun; 26(6):2032-6. PubMed ID: 21543655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome according to renal histological lesions in 118 patients with monoclonal gammopathies.
    Montseny JJ; Kleinknecht D; Meyrier A; Vanhille P; Simon P; Pruna A; Eladari D
    Nephrol Dial Transplant; 1998 Jun; 13(6):1438-45. PubMed ID: 9641173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term prognosis of AL and AA renal amyloidosis: a Japanese single-center experience.
    Ozawa M; Komatsuda A; Ohtani H; Nara M; Sato R; Togashi M; Takahashi N; Wakui H
    Clin Exp Nephrol; 2017 Apr; 21(2):212-227. PubMed ID: 27116248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome.
    Bergesio F; Ciciani AM; Manganaro M; Palladini G; Santostefano M; Brugnano R; Di Palma AM; Gallo M; Rosati A; Tosi PL; Salvadori M;
    Nephrol Dial Transplant; 2008 Mar; 23(3):941-51. PubMed ID: 17951308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome of live donor kidney transplantation for renal amyloidosis.
    Sherif AM; Refaie AF; Sobh MA; Mohamed NA; Sheashaa HA; Ghoneim MA
    Am J Kidney Dis; 2003 Aug; 42(2):370-5. PubMed ID: 12900821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Heart transplantation and the subsequent treatment of AL amyloidosis].
    Adam Z; Krejčí J; Krejčí M; Němec P; Spinarová L; Zampachová V; Cermáková Z; Pika T; Pour L; Kořístek Z; Tomíška M; Szturz P; Král Z; Mayer J
    Vnitr Lek; 2013 Feb; 59(2):136-47. PubMed ID: 23461404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-Dose Melphalan and Stem Cell Transplantation in Patients on Dialysis Due to Immunoglobulin Light-Chain Amyloidosis and Monoclonal Immunoglobulin Deposition Disease.
    Batalini F; Econimo L; Quillen K; Sloan JM; Sarosiek S; Brauneis D; Havasi A; Stern L; Dember LM; Sanchorawala V
    Biol Blood Marrow Transplant; 2018 Jan; 24(1):127-132. PubMed ID: 28865972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
    Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
    Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Heart transplantation and follow-up treatment with AL-amyloidosis in 5 patients].
    Adam Z; Ozábalová E; Němec P; Bedáňová H; Kuman M; Krejčí J; Špinarová L; Žampachová V; Čermáková Z; Pour L; Krejčí M; Sanecká V; Štork M; Pika T; Straub J; Adamová D; Stavařová Y; Král Z; Mayer J
    Vnitr Lek; 2018; 64(4):441-449. PubMed ID: 29791180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double organ transplantation in cardiac amyloidosis.
    Gkouziouta A; Farmakis D; Manginas A; Sfyrakis P; Saroglou G; Adamopoulos S; Iliodromitis EK
    J Cardiovasc Med (Hagerstown); 2016 Feb; 17(2):126-9. PubMed ID: 25333376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney transplantation for end-stage renal disease secondary to familial Mediterranean fever.
    Altindal M; Turkmen E; Yildirim T; Yilmaz R; Aki FT; Arici M; Altun B; Erdem Y
    Clin Transplant; 2016 Jul; 30(7):787-90. PubMed ID: 27101228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features of patients with immunoglobulin light chain amyloidosis (AL) with vascular-limited deposition in the kidney.
    Eirin A; Irazabal MV; Gertz MA; Dispenzieri A; Lacy MQ; Kumar S; Sethi S; Nasr SH; Cornell LD; Fidler ME; Fervenza FC; Leung N
    Nephrol Dial Transplant; 2012 Mar; 27(3):1097-101. PubMed ID: 22067518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial comment for Korman et al.
    Low RK
    J Endourol; 2011 Jan; 25(1):127. PubMed ID: 21247291
    [No Abstract]   [Full Text] [Related]  

  • 17. Benign monoclonal gammopathy turning to AL amyloidosis after kidney transplantation.
    Dysseleer A; Michaux L; Cosyns JP; Goffin E; Hermans C; Pirson Y
    Am J Kidney Dis; 1999 Jul; 34(1):166-9. PubMed ID: 10401033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin light chain amyloidosis is diagnosed late in patients with preexisting plasma cell dyscrasias.
    Kourelis TV; Kumar SK; Go RS; Kapoor P; Kyle RA; Buadi FK; Gertz MA; Lacy MQ; Hayman SR; Leung N; Dingli D; Lust JA; Lin Y; Zeldenrust SR; Rajkumar SV; Dispenzieri A
    Am J Hematol; 2014 Nov; 89(11):1051-4. PubMed ID: 25111004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose intravenous melphalan with autologous stem cell transplantation in AL amyloidosis-associated end-stage renal disease.
    Casserly LF; Fadia A; Sanchorawala V; Seldin DC; Wright DG; Skinner M; Dember LM
    Kidney Int; 2003 Mar; 63(3):1051-7. PubMed ID: 12631087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current and emerging views and treatments of systemic immunoglobulin light-chain (Al) amyloidosis.
    Comenzo RL
    Contrib Nephrol; 2007; 153():195-210. PubMed ID: 17075231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.